Direct-to-Patient Registries: A New Approach to Pharmacovigilance

Direct-to-Patient Registries: A New Approach to Pharmacovigilance


Authored by: Nancy Dreyer, MPH, Ph.D., Global Chief of Scientific Affairs and Michelle Leavy, MPH, Manager, Health Policy, Quintiles

Published in: BioScience Technology – 28th October 2015

Industry thought-leader Nancy Dreyer reviews the latest thinking in pharmacovigilance and the promise of direct-to-patient registries. Nancy outlines Quintiles’ involvement in the PROTECT (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium) study and highlights that “with the rapid advance of technology, we have seen a number of non-traditional approaches to AE reporting cropping up… the web-based solution offered by MyMeds&Me offers an intuitive, standardized method of capturing AE data via SaaS. Patients can simply point and click on “where it hurts” to generate direct-from-patient data nearly instantly.”

Access the full article here

Request More Information

To find out more or request a demo fill in the details below:

By submitting your information, you are consenting to receive communications from MyMeds&Me. You may at any time 'opt out' of receiving these marketing communications by emailing